Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia. Chestnykh D, Muhle C, Schumacher F, Kalinichenko LS, et al. Mol Psychiatry 2025 Jan 17. doi: 10.1038/s41380-025-02893.

Read + Share

Amedeo Smart

Independent Medical Education

Chestnykh D, Muhle C, Schumacher F, Kalinichenko LS, et al. Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia. Mol Psychiatry 2025 Jan 17. doi: 10.1038/s41380-025-02893.
PMID: 39825014